Market Research Reports

All Reports Home

Categories

Countries

Pharmaceuticals Reports

Ovarian Cancer Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Drug Class (Alkylating Agents, Mitotic Inhibitors, Antirheumatics, Antipsoriatics, VEGF/VEGFR Inhibitors, PARP Inhibitors, Antineoplastics, Others), By Tumor Type (Epithelial Ovarian Cancer, Ovarian Low Malignant Potential Tumor, Germ Cell Tumor, Sex Cord-Stromal Tumor), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region

Increasing occurrence of ovarian cancer is expected to drive the growth of global ovarian cancer drugs market in the forecast period, 2023-2027.Read More

Microbiome Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Type (FMT v/s Microbiome Drugs), By Application (C. Difficile, Crohn’s Disease, Inflammatory Bowel Disease, Diabetes, Others), By Region

Growing prevalence of target diseases is expected to drive the growth of global microbiome therapeutics market in the forecast period, 2023-2027.Read More

Global Bleeding Disorders Treatment Market By Drug Type (Plasma-derived Coagulation Factor Concentrates, Recombinant Coagulation Factor Concentrates, Desmopressin, Antifibrinolytics, Fibrin Sealants, Others) By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online) By End User (Clinics, Hospitals, Research Institutes, Others) By Region, Competition Forecast & Opportunities, 2027

Increasing number of bleeding disorder patients is driving the Global Bleeding Disorders Treatment Market growth in the forecast period, 2023-2027.Read More

Global Central Nervous System Therapeutics Market By Drug Class (Multiple Sclerosis, Antipsychotic, Antiepileptics, Analgesics & Anesthetics, Anti-Parkinson, Others), By Application (Neurodegenerative Diseases, Mental Health and Trauma, Neurovascular Diseases, Infectious Diseases, CNS Cancer, Others), By Route of Administration (Oral, Parenteral, Others), By End User (Hospital, Clinics, Diagnostic Laboratories, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By Region, Competition Forecast & Opportunities, 2026

Demand for effective therapeutics for treatment of CNS is a driving factor for the growth of Global Central Nervous System Therapeutics Market through 2026.Read More

Travel Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Composition (Mono Vaccines v/s Combination Vaccines), By Disease Indication (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, Others), By Travel Type (Domestic v/s International) and By Region

Increased aviation spending from government and private industrialists is expected to drive the growth of global travel vaccine market in the forecast period, Read More

Egypt Hepatitis C Treatment Drug Market By Disease Type (Acute v/s Chronic), By Drug Class (Combination Therapy, Protease Inhibitors, Polymerase Inhibitors, Immunomodulators, Antiviral Medications, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Region, Competition Forecast & Opportunities, 2027

The rising cases of hospital-acquired infections and blood transfusion diseases are primarily leading to the rising cases of Hepatitis C, which eventually is Read More

United Kingdom Pharmaceutical Market By Drug Type (Generic Drugs v/s Branded Drugs), By Product Type (Prescription Drugs v/s Over-The-Counter Drugs), By Application (Cardiovascular, Musculoskeletal, Oncology, Anti-infective, Metabolic Disorder, Others), By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Pharmacy), By Region, Competition Forecast & Opportunities, 2027

Continuous technological advancements in the healthcare sector across United Kingdom and the escalating demand for precision medicine are projected to catalyze Read More

Oncology Precision Medicine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 By Ecosystem (Precision Diagnostics, Precision Therapeutics, Applied Sciences, Digital Health, and Information Technology), Precision Diagnostics (Molecular Diagnostics v/s Medical Imaging), Precision Therapeutics (Clinical Trials, Cell Therapy, Drug Discovery & Research, Gene Therapy), Applied Sciences (Genomics, Pharmacogenomics, Others), Digital Health, and Information Technology (Clinical Decision Support Systems (CDSS), Big Data Analytics, Genomics Informatics, In-Silico Informatics, Others), By Application (Solid Tumor v/s Hematological Malignancies), Solid Tumor (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Others), Hematological Malignancies (Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Leukemia, Others), and By Region

Expanding prevalence of CNS disorders and escalating adoption of gene therapy are anticipated to catalyze the market growth, in the forecast period, 2023-2027. Read More

Molnupiravir Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Application (Influenza, Ebola, COVID-19, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region

Growth of the Global Molnupiravir Market may increase on backbone of innovative drug formulations against COVID-19 in the recent years.Read More

United Kingdom Generic Drugs Market By Type (Small Molecule Generics v/s Biosimilars), By Mode of Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House v/s Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others), By Region, Competition Forecast & Opportunities, 2027

United Kingdom Generic Drugs Market anticipated to grow during forecast period on the backbone of expanding pharmaceutical industry. Read More

India Tomato Fever Therapeutics Market By Drug Type (Pain Relievers, Non-Steroidal Anti-inflammatory Drugs, Nucleoside Analogue Antivirals), By Route of Administration (Topical, Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region (Top 3 States), Competition Forecast & Opportunities, 2028

Rising instances of tomato fever is driving the growth of the India tomato fever therapeutics market in the upcoming five years.Read More

Japan Clinical Nutrition Market By Nutrition Type (Enteral Nutrition v/s Parental Nutrition), By Route of Administration (Oral v/s Intravenous), By Substrate (Energy, Carbohydrates, Lipids, Proteins & Amino Acids, Water & Electrolyte, Dietary fiber, Antioxidants), By Application (Metabolic Disorders, Eating Disorders, Stages of Development and Recovery, Others), By End User (Infant & Child, Adults, Geriatrics), By Region, Competition Forecast & Opportunities, FY2027

Increasing prevalence of inactive lifestyle and rise in cardiovascular disorders are expected to drive the demand for the Japan Clinical Nutrition Market in the Read More

United States Cannabis Market By Product Type (Flower, Concentrates), By Compound (THC-Dominant, CBD-Dominant, and Balanced THC & CBD), By Application (Medical and Recreational), By Region, By Company, Competition, Forecast & Opportunities, 2027

Adoption of cannabis as a pharmaceutical product and increasing legalisation of cannabis are the major factor propelling the growth of United States Cannabis Read More

Global Nootropics Market By Type (Prescription v/s Over the Counter) By Product Type (Natural v/s Synthetic) By Distribution Channel (Online v/s Offline) By Application (Memory Enhancement, Mood & Depression, Attention & Focus, Longevity & Anti-aging, Sleep & Recovery, Anxiety, Others) By Region, Competition Forecast & Opportunities, 2027

Increasing demand for mind boosters is driving the growth in Global Nootropics Market in the forecast period, 2023-2027.Read More

Global Ophthalmic Drugs Market By Drug Class (Anti-Inflammatory Drugs, Anti-Infection Drugs, Anti-Allergic Drugs, Anti-Glaucoma Drugs, Others) By Indication (Dry Eye, Eye Allergy, Glaucoma, Eye Infection, Others) By Product Type (OTC Drugs v/s Prescription Drugs) By Dosage Form (Gels, Ointments, Eye Solutions, Eye Drops, Tablets &Capsules) By Route of Administration (Topical, Ocular, Systemic) By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) By Region, Competition Forecast & Opportunities, 2027

Rising concerns for eye diseases is driving the growth in Global Ophthalmic Drugs Market in the forecast period, 2023-2027. Read More

Aseptic Pharma Processing Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2017-2027, Segmented By Component (Processing Equipment {Drying Equipment, Extruders, Granulation Equipment, Tablet Compression, Fill/Finish Equipment, Mixing Equipment, Others} v/s Packaging Equipment {Inspection Machines, Labelling Machines, Aseptic Packaging Machines}), By Technology (Drying, Lyophilization, Closed Vial Technology, Blow Fill Seal Technology, Others), By Product (Corticosteroids, Antibiotics, Antagonists, Biologics, Others), By Application (Ophthalmic Suspensions, Reconstituted Lyophilized Powders for Injection, Sterile Injectables, Aqueous-Based Aerosols for Inhalation, Others), By Region

High capital investment in the pharmaceutical industry is driving the growth of Global Aseptic Pharma Processing Market in the forecast period, 2023-2027. Read More

Australia Regenerative Medicine Market By Type (Cell Therapy, Gene Modification, Tissue Engineering, Others), By Application (Bone Graft Substitutes, Osteoarticular Diseases, Dermatology, Cardiovascular Diseases, Others), By End User (Academic v/s Commercial), By Region, Competition Forecast & Opportunities, 2027

Advancing drug designing is driving the growth of Australia Regenerative Medicine Market, in the forecast period, 2023-2027.Read More

Vietnam Generic Drugs Market By Type (Small Molecule Generics v/s Biosimilars), By Mode of Drug Delivery (Oral, Topical, Parenteral, Others), By Form (Tablet, Capsule, Injection, Others), By Source (In House v/s Contract Manufacturing Organizations), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Application (Cardiovascular Diseases, Diabetes, Neurology, Oncology, Anti-Inflammatory Diseases, Others), By Region, Competition Forecast & Opportunities, 2027

Higher sales of over the counter drugs are driving the growth of Vietnam Generic Drugs Market, in the forecast period, 2023-2027. Read More

Middle East & Africa Active Pharmaceutical Ingredient Market By Method of Synthesis (Biological v/s Synthetic) By Source (Contact Manufacturing Organizations v/s In-House Manufacturing) By Therapeutic Application (Cardiovascular Diseases, Anti-diabetic Drugs, Oncology Drugs, Neurological Disorders, Musculoskeletal Disorders, Others) By Molecule Type (Small v/s Large) By Potency (Low v/s High) By Drug Type (Innovator v/s Generics) By Country, Competition Forecast & Opportunities, 2027

Advancing medical sector drives the Middle East & Africa Active Pharmaceutical Ingredient Market growth in the forecast period, 2023-2027F.Read More

United States Human Insulin Market By Indication (Type 1 Diabetes v/s Type 2 Diabetes) By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection) By Type (Basal, Bolus, Pre-Mixed, Biosimilar, Traditional) By Onset Time (Rapid Acting, Short Acting, Intermediate Acting, Long Lasting, Others) By Brand (Lantus, Humulin R, Novolin R, Humulin N, Exubera, Others) By Region, Competition Forecast & Opportunities, 2027

Surge in diabetic patients is driving the growth of United States Human Insulin Market, in the forecast period.Read More

Prev    Page 19 of 23 Next